BME7900 Semiar Series - Robert Schwartz, MD, PhD
Weill Hall 226
Our next speaker we welcome in our series is Dr. Robert Schwartz from Weill Cornell Medicine. Dr. Schwartz is also applying for Field Membership with the Meinig School of Biomedical Engineering.
Modeling Human Disease Using Bioengineered Tissues
Bio: Dr. Robert Schwartz completed his B.E. in chemical engineering from the Cooper Union in New York City, his Ph.D. in biomedical engineering and M.D. at the University of Minnesota in Minneapolis. His thesis work was on the derivation of stem cell-derived hepatocytes and in vitro liver model systems. He completed his residency in internal medicine at Washington University in St. Louis/Barnes Jewish Hospital. His fellowship in gastroenterology and hepatology was completed at the Brigham and Women’s Hospital in Boston, Mass. He did a postdoctoral fellowship at Massachusetts Institute of Technology (MIT) in the laboratory of Dr. Sangeeta Bhatia. My career goal as an independent physician scientist investigator in the fields of gastroenterology and hepatology, biomedical engineering, stem cell, and regenerative medicine is to develop new platforms for hepatocyte study and to build and translate ideas and discoveries in the laboratory to the clinic. My work has involved the development of new stem cell techniques and model systems with the goal to better understand human disease and to develop new clinical treatments. My work has led to 86 publications. I continue to focus on the many challenges in the derivation of new model systems to study human hepatotropic diseases and am interested in the challenges of clinical translation of stem cell derived hepatocytes and primary human hepatocytes. We are currently leveraging these mini-tissues as model platforms to study human liver diseases including genetic, metabolic disorders, and infectious diseases.